Solid Biosciences

Solid Biosciences is a precision genetic medicine company focused on developing gene therapy candidates for rare neuromuscular and cardiac diseases. Its lead program is SGT-003 for Duchenne muscular dystrophy, and the pipeline also includes programs for Friedreich's ataxia and inherited cardiac conditions.

Relationship details are part of the Pro plan.